Oral GLP-1 tablets · orforglipron
Foundayo (orforglipron): UK guide
Foundayo at a glance
- Active ingredient
- orforglipron
- Drug class
- Non-peptide (small-molecule) GLP-1 receptor agonist
- Manufacturer
- Eli Lilly
- How it is taken
- Tablet, once a day
- Dose range
- 0.8mg to 17.2mg
- How to take it
- Take once a day at any time of day, with or without food. There are no food or water restrictions.
- MHRA authorisation
- MHRA authorised for weight management and type 2 diabetes, 10 August 2026
- NICE guidance
- Not yet verified
Regulatory source: gov.uk
Licensed in the UK for weight management. MHRA authorised for weight management and type 2 diabetes, 10 August 2026.
The main clinical evidence for Foundayo in weight management comes from the ATTAIN trial programme. Read what the trials show for context on realistic expectations.
Foundayo doses
| Dose | Role | Earliest start (if increased at every step) |
|---|---|---|
| Foundayo 0.8mg | Starting dose | Week 1 |
| Foundayo 2.5mg | Step-up dose | Week 5 |
| Foundayo 5.5mg | Step-up dose | Week 9 |
| Foundayo 9mg | Maintenance dose | Week 13 |
| Foundayo 14.5mg | Maintenance dose | Week 17 |
| Foundayo 17.2mg | Maximum dose | Week 21 |
- Step 10.8mgfrom week 1
- Step 22.5mgfrom week 5
- Step 35.5mgfrom week 9
- Step 49mgfrom week 13
- Step 514.5mgfrom week 17
- Step 617.2mgfrom week 21
The UK product information says to stay on each dose for at least 4 weeks before increasing. Weeks shown are the earliest possible; many people stay on a dose for longer, and some stay on a lower dose.
Foundayo side effects
Commonly reported
Serious: know the signs
When to get urgent help
Stop taking the medicine and get urgent medical help (NHS 111, A&E or 999) if you have severe, persistent stomach pain that may spread to your back, signs of a serious allergic reaction, or yellowing of your skin or eyes. Report suspected side effects to the MHRA Yellow Card scheme.
Everything about Foundayo
How Foundayo compares
UK providers listing Foundayo
We have not yet verified which providers offer Foundayo.
Foundayo guides
- Oral GLP-1 Medications in the UK: The Complete Guide
- Weight Loss Tablets in the UK: What's Licensed and What the Evidence Says
- Oral Semaglutide: How the Wegovy Tablet Works
- Foundayo (Orforglipron): The Small-Molecule GLP-1 Tablet Explained
- Tablets vs Injections: Oral and Injectable GLP-1s Compared
- Rybelsus and Weight Loss: Why It's Licensed for Diabetes, Not Obesity
- Orlistat vs GLP-1 Medications: How They Compare
- Oral GLP-1 Side Effects: What to Expect from Tablet Treatment
- Switching from an Injection to a GLP-1 Tablet